BAP1 and cutaneous melanoma: The syndrome should be suspected in individuals with two or more confirmed BAP1-TPDS tumors or one confirmed BAP1-TPDS tumor accompanied by a first- or second-degree relative with a confirmed BAP1-TPDS tumor (excluding basal cell carcinomas and cutaneous melanomas, which are prevalent in the general population).